These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 27984723)

  • 21. Aged induced pluripotent stem cell (iPSCs) as a new cellular model for studying premature aging.
    Petrini S; Borghi R; D'Oria V; Restaldi F; Moreno S; Novelli A; Bertini E; Compagnucci C
    Aging (Albany NY); 2017 May; 9(5):1453-1469. PubMed ID: 28562315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
    Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
    Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic Acid Inducible Gene 1 Protein (RIG1)-Like Receptor Pathway Is Required for Efficient Nuclear Reprogramming.
    Sayed N; Ospino F; Himmati F; Lee J; Chanda P; Mocarski ES; Cooke JP
    Stem Cells; 2017 May; 35(5):1197-1207. PubMed ID: 28276156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of cellular rejuvenation.
    Denoth-Lippuner A; Jessberger S
    FEBS Lett; 2019 Dec; 593(23):3381-3392. PubMed ID: 31197818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial Reprogramming as a Method for Regenerating Neural Tissues in Aged Organisms.
    Sichani AS; Khoddam S; Shakeri S; Tavakkoli Z; Jafroodi AR; Dabbaghipour R; Sisakht M; Fallahi J
    Cell Reprogram; 2024 Feb; 26(1):10-23. PubMed ID: 38381402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.
    Fritz AL; Adil MM; Mao SR; Schaffer DV
    Mol Ther; 2015 May; 23(5):952-963. PubMed ID: 25666918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attempting to Convert Primed Porcine Embryonic Stem Cells into a Naive State Through the Overexpression of Reprogramming Factors.
    Park TY; Choi KH; Lee DK; Oh JN; Kim SH; Lee CK
    Cell Reprogram; 2018 Oct; 20(5):289-300. PubMed ID: 30277824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells.
    Phanthong P; Raveh-Amit H; Li T; Kitiyanant Y; Dinnyes A
    Biogerontology; 2013 Dec; 14(6):591-602. PubMed ID: 23963527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic regulation leading to induced pluripotency drives cancer development in vivo.
    Ohnishi K; Semi K; Yamada Y
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):10-5. PubMed ID: 25019993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative Binding of Transcription Factors Orchestrates Reprogramming.
    Chronis C; Fiziev P; Papp B; Butz S; Bonora G; Sabri S; Ernst J; Plath K
    Cell; 2017 Jan; 168(3):442-459.e20. PubMed ID: 28111071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient transcription factor (OSKM) expression is key towards clinical translation of
    de Lázaro I; Cossu G; Kostarelos K
    EMBO Mol Med; 2017 Jun; 9(6):733-736. PubMed ID: 28455313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo reprogramming leads to premature death linked to hepatic and intestinal failure.
    Parras A; Vílchez-Acosta A; Desdín-Micó G; Picó S; Mrabti C; Montenegro-Borbolla E; Maroun CY; Haghani A; Brooke R; Del Carmen Maza M; Rechsteiner C; Battiston F; Branchina C; Perez K; Horvath S; Bertelli C; Sempoux C; Ocampo A
    Nat Aging; 2023 Dec; 3(12):1509-1520. PubMed ID: 38012287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency.
    Jo J; Hwang S; Kim HJ; Hong S; Lee JE; Lee SG; Baek A; Han H; Lee JI; Lee I; Lee DR
    Nucleic Acids Res; 2016 Feb; 44(3):1203-15. PubMed ID: 26740582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic Acid Enhances iPSC Induction From Human Bone Marrow-Derived Cells Through the Suppression of Reprogramming-Induced Senescence.
    Chen X; Zhai Y; Yu D; Cui J; Hu JF; Li W
    J Cell Physiol; 2016 Aug; 231(8):1719-27. PubMed ID: 26620855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming.
    Cipriano A; Moqri M; Maybury-Lewis SY; Rogers-Hammond R; de Jong TA; Parker A; Rasouli S; Schöler HR; Sinclair DA; Sebastiano V
    Nat Aging; 2024 Jan; 4(1):14-26. PubMed ID: 38102454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRIM28 epigenetic corepressor is indispensable for stable induced pluripotent stem cell formation.
    Klimczak M; Czerwińska P; Mazurek S; Sozańska B; Biecek P; Mackiewicz A; Wiznerowicz M
    Stem Cell Res; 2017 Aug; 23():163-172. PubMed ID: 28759843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem cells.
    Shinagawa T; Takagi T; Tsukamoto D; Tomaru C; Huynh LM; Sivaraman P; Kumarevel T; Inoue K; Nakato R; Katou Y; Sado T; Takahashi S; Ogura A; Shirahige K; Ishii S
    Cell Stem Cell; 2014 Feb; 14(2):217-27. PubMed ID: 24506885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pluripotency, Differentiation, and Reprogramming: A Gene Expression Dynamics Model with Epigenetic Feedback Regulation.
    Miyamoto T; Furusawa C; Kaneko K
    PLoS Comput Biol; 2015 Aug; 11(8):e1004476. PubMed ID: 26308610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.